Neumora Therapeutics Has Initiated A Phase 1 Single Ascending Dose / Multiple Ascending Dose Study Of NMRA-266 In Healthy Adult Participants For Schizophrenia And Other Neuropsychiatric Disorders
Neumora Therapeutics Has Initiated A Phase 1 Single Ascending Dose / Multiple Ascending Dose Study Of NMRA-266 In Healthy Adult Participants For Schizophrenia And Other Neuropsychiatric Disorders
Neumora Therapeutics 已启动一项针对精神分裂症和其他神经精神疾病的健康成年参与者 NMRA-266 的 1 期单剂量递增剂量/多剂量递增剂量研究
Neumora Therapeutics Has Initiated A Phase 1 Single Ascending Dose / Multiple Ascending Dose Study Of NMRA-266 In Healthy Adult Participants For Schizophrenia And Other Neuropsychiatric Disorders
Neumora Therapeutics 已启动一项针对精神分裂症和其他神经精神疾病的健康成年参与者 NMRA-266 的 1 期单剂量递增剂量/多剂量递增剂量研究